William Roth

William Roth has been an investments writer since 2005 and has a keen interest in monetary policy, the ever expanding limits of government intervention in the economy and stocks, and behavioral finance. He uses a combination of quantitative screening and technical analysis to identify market trends at the sector and individual holding level. His work has appeared in such outlets as MSN Money and Yahoo Finance. He has an Bachelor of Arts in finance.

Recent Articles

4 Retail Stocks to Buy Getting Marked Up for Black Friday

These four retail stocks are big names in their sector, but they're also gearing up to make big moves as Black Friday approaches.

4 Stocks Driving the Dow to New Records

The DJIA is clawing to new highs and exiting a two-year consolidation range. It's arching towards the 28,000 level for the first time.

5 Chinese Stocks to Buy Surging Higher

U.S.-listed Chinese stocks are surging higher on the hopes that a deal is forthcoming. Here are five Chinese stocks to buy worth a look.

4 Startup Stocks Getting Smashed

Sentiment is evaporating for ultra-hyped IPOs that attracted billions in market value only to wilt under the spotlight of the public markets.

4 Consumer Technology Stocks to Buy Now

As investors anticipate positive developments in the China trade war, these are some of the tech stocks to buy on the news.

5 Transportation Stocks to Buy Now    

Stocks are up almost across the board, and these transportation stocks all seem to be building toward more upside.

4 Energy Stocks to Sell

A number of key oil field services and oil production stocks are rolling over. Here are four stocks to sell now.

5 Stocks Powering the S&P 500 to New Highs

A number of large-cap stocks, particularly in the tech space, are perking up nicely into fresh rallies. Here are five stocks to buy.

5 Dow Jones Industrial Average Stocks to Sell

A number of Dow Jones component stocks are weakening badly. Here are five to sell now including 3M, Boeing, and Nike.

5 Healthcare Stocks to Buy

Healthcare in particular is one such sector, with a number of large-cap biotechnology and pharmaceutical stocks enjoying fresh rallies.